Atara Biotherap
(ATRA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 48,162 | 46,207 | 26,550 | 22,250 | 23,940 |
| Marketable Securities | 207,714 | 232,134 | 268,201 | 284,347 | 296,736 |
| TOTAL | $260,553 | $282,230 | $298,883 | $311,741 | $324,597 |
| Non-Current Assets | |||||
| PPE Net | 3,259 | 2,085 | 1,830 | 1,148 | 270 |
| Other Non-Current Assets | 102 | 102 | 101 | 89 | 108 |
| TOTAL | $3,361 | $2,187 | $1,931 | $1,237 | $378 |
| Total Assets | $263,914 | $284,417 | $300,814 | $312,978 | $324,975 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,778 | 4,463 | 3,235 | 1,896 | 1,445 |
| Accrued Expenses | 3,745 | 3,156 | 2,135 | 1,337 | 2,624 |
| TOTAL | $9,675 | $13,688 | $10,006 | $8,860 | $9,709 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 503 | 527 | 563 | 284 | 166 |
| TOTAL | $503 | $527 | $563 | $284 | $166 |
| Total Liabilities | $10,178 | $14,215 | $10,569 | $9,144 | $9,875 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,164 | 1,154 | 1,152 | 1,150 | 1,148 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | -177,159 | -158,924 | -133,551 | -114,671 | -98,110 |
| Other shareholders' equity | -183 | 35 | 193 | 51 | -518 |
| TOTAL | $253,736 | $270,202 | $290,245 | $303,834 | $315,100 |
| Total Liabilities And Equity | $263,914 | $284,417 | $300,814 | $312,978 | $324,975 |